NOVEL HAEMOPHILUS PARASUIS ANTIGEN

PURPOSE: A vaccine composition containing a haemophilus parasuis infection including OppA, YfeA, PlpA, or CsgG peptides is provided to ensure excellent efficiency without side effect. CONSTITUTION: A vaccine composition for preventing or treating a haemophilus parasuis infection contains OppA of seq...

Full description

Saved in:
Bibliographic Details
Main Authors YOO, SUNG SIK, JUNG, JOON KI, YOON, IN JOONG, LEE, EUN GYO, LEE, HONG WEON, HONG, MIN HEE, KIM, CHUN SUG, AHN, JUNG OH, LEE, JOO HWAN, LEE, HYEOK WON
Format Patent
LanguageEnglish
Korean
Published 02.01.2012
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PURPOSE: A vaccine composition containing a haemophilus parasuis infection including OppA, YfeA, PlpA, or CsgG peptides is provided to ensure excellent efficiency without side effect. CONSTITUTION: A vaccine composition for preventing or treating a haemophilus parasuis infection contains OppA of sequence number 1, YfeA of sequqnce number 2, PlpA of sequence number 3, or CsgG of sequence number 4. The peptides are isolated from haemophilus parasuis. A vaccine composition or medicinal composition for preventing or treating Glasser's disease contains the peptides of OppA, YfeA, PlpA, or CsgG.
Bibliography:Application Number: KR20100060782